The Hindu Business Line : Pfizer, Pharmacia boards clear merger

THE boards of Pfizer Ltd and Pharmacia Healthcare Ltd (PHL) have approved the scheme of amalgamation of the two companies and fixed an exchange ratio of five shares of PHL to one Pfizer share.

The face value of PHL and Pfizer's equity share is Rs 5 and Rs 10 each, respectively, the companies informed the Bombay Stock Exchange on Wednesday. The scheme of amalgamation is, however, subject to approval from shareholders and the Bombay High Court, the company said.

The parent company, Pfizer Inc, holds 75 per cent equity in Pharmacia Healthcare and 40 per cent in Pfizer Ltd.

Globally, the Pharmacia merger happened when the acquisition took place in 2003 and this development brought two companies into the Pfizer fold — PHL and Pharmacia India Pvt Ltd, now a 100 per cent subsidiary of Pfizer. The operational integration of PHL with Pfizer Ltd was done in 2003.

More Stories on : Mergers & Acquisitions | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Nagarjuna Construction gets Rs 240-cr orders

Control of MP Birla group — Universal Cables, Vindhya Telelinks hold the key

Birla family holds meeting; Lodha stays away from office

Priyamvada's will: R.S. Lodha files caveat

Pfizer, Pharmacia boards clear merger

Days Inn Deccan in Chennai

APSFC to aid Govt in rehabilitating sick industries

Exide powers global initiatives — Deals with Russian Navy, China co on anvil

Exide chief concern over lead prices

BPCL looks for partners in airport privatisation

Budget levies will impact ONGC bottomline: Raha

Ashok Leyland pitches for maintenance contract for Defence vehicles

Revathi Equipment eyeing new acquisitions, tie-ups

For investor-friendly annual reports — Govt may ease disclosure norms for subsidiary cos